MR cracks ‘age-doping” in international youth soccer

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 10
Volume 31
Issue 10

MRI has been adopted by the International Federation of Association Football as a definitive measure to ensure fair play.

MRI has been adopted by the International Federation of Association Football as a definitive measure to ensure fair play.

FIFA, the governing body for international soccer competition, launched a program of random MRI wrist screening this month to verify the age of players competing in the U-17 (under 17) World Cup, which is being hosted by Nigeria. The issue of fielding overage players has been around for some time because the global competition draws talent from many parts of the world where age cannot be clearly determined. With this method, FIFA will guarantee that all players are really biologically under 17, according to FIFA's chief medical officer, Prof. Jiri Dvorak.

“MRI can determine age below or over 17 with a certainty of 99%,” he said.

FIFA-sanctioned competitions had used x-rays for this purpose in the past. But several member associations raised concerns about the use of ionizing radiation. This led the organization to look to MRI instead, Dvorak said.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
A Closer Look at the Impact of Expanded Mammography Coverage in Missouri: An Interview with Amy Patel, MD
New Mammography Research Examines Impact of High-Resolution DBT
Can Radioligand Therapy Have an Impact for Women with Breast Cancer?
Emerging Concepts in CT-Guided Treatment of Coronary Artery Disease
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.